Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Live Terminal
Economy · Full coverage

Teva Pharmaceutical Industries Achieves Investment-Grade Credit Rating

How 2 Israeli newsrooms covered this story — translated into English and compared side by side.

Unrated 2

By מערכת ice

First reported by Bizportal · 2 days ago

What happened

Teva Pharmaceutical Industries has achieved an investment-grade credit rating from S&P Global Ratings, marking the third major agency to do so. This upgrade reflects the company's successful turnaround strategy, debt reduction efforts, and growth potential.

  • 01S&P Global Ratings upgraded Teva's credit rating to investment-grade BBB minus.
  • 02This is Teva's third credit rating upgrade in recent months.
  • 03Teva now holds investment-grade ratings from all three major agencies.
  • 04The upgrades reflect Teva's successful 'Pivot to Growth' strategy.
  • 05The company has made significant progress in debt reduction.
  • 06S&P cited Teva's strong growth potential and product pipeline.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story
People
OrganizationsS&P Global Ratings, Fitch, Moody's, Teva Pharmaceutical Industries

Full coverage · 2 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

IceUnrated · Hebrew1 day ago
Teva Pharmaceutical Industries Achieves Investment-Grade Credit Rating
BizportalUnrated · Hebrew2 days ago
Teva Pharmaceutical Industries Earns Investment-Grade Credit Rating

Related stories

Teva Pharmaceuticals Refinances Debt Following Credit Rating Upgrades14 hours agoTeva's Stock Surges as It Eyes Inclusion in S&P 500 Following Strong Q2 ResultsJul 29, 2026Israeli Pharma Company Teva Beats Expectations and Raises 2026 Revenue ForecastJul 29, 2026Teva Shares Continue Decline Amid Market Volatility and Sector ComparisonsJul 19, 2026Teva Finance Chief Sells Nearly NIS 62 Million in Shares as Stock SurgesJun 16, 2026Teva's Former Israeli-Traded Pharma Giant Perrigo Collapses After Delisting, Sparing Local Investors Heavy LossesJun 30, 2026